11 Jan 2019 Governance
Leukaemia UK and Leuka have merged
We are delighted to announce that on 1 November Leuka and Leukaemia UK merged, bringing together two of the UK’s leading leukaemia and blood cancer charities to create one charity dedicated to innovative research and care for people affected by blood cancers. The two charities have joined forces under the name Leukaemia UK, uniting Leuka’s 37 years’ experience in ground-breaking medical research with Leukaemia UK’s four decades of pioneering care.
From research to care, the new charity will continue to put people affected by blood cancers at its heart. Together, Leukaemia UK aims to carry out even more world-class research and advances in care.
Leukaemia UK will be led jointly by Leuka’s CEO Olive Boles and Leukaemia UK’s CEO Angela Smith-Morgan. The charity’s new Chair of Trustees is Chris Corbin, current Chair of Leuka, who is supported by a Board including both Leuka and Leukaemia UK Trustees.
Related posts
10 January 2023
Clinical trial begins for pioneering new cancer treatment
Dr Konstantinos Tzelepis was awarded a Leukaemia UK research fellowship in 2020 and has developed a new class of cancer drug with the potential to treat leukaemia.
4 August 2020
Our life-saving work must continue
Leukaemia and other blood cancers don’t stop for coronavirus (COVID-19) and our vital research and care must continue
11 February 2021
Why I became a Leukaemia UK Trustee
Caroline Evans – Leukaemia UK Trustee and Projects Consultant – reflects on why she became a Trustee and what drives her in the role.
30 March 2022
One Cancer Voice 10-Year Cancer Plan Consensus Statement
We have joined with 53 cancer charities to speak with One Cancer Voice and publish 10 tests that the Government’s new 10-year Cancer Plan must meet if it is to be successful.